Authors
Loading...
Investigating interleukin effects on T-cell activity with Src/BCR-ABL1 inhibition in Ph+ ALL, suggesting enhanced therapies.
Naeemikia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: